Dr. Al Hallak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 John R St
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8766
Summary
- I am a board-certified physician with special expertise in Medical Oncology. I focus my clinical practice on Gastrointestinal (GI) malignancies including Pancreatic cancer, neuroendocrine tumors, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Biliary Cancer etc.
My research focus is in Gastrointestinal Malignancies, specifically pancreatic cancer, with a goal to better understand the molecular biology and microenvironment of GI cancers, discover new treatments and prevent treatment-related toxicities. I have a special interest and expertise in conducting clinical trials ranging from Phase I (first-in-human) to more expanded, efficiency-testing, Phase II-II trials.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020
University of MichiganMS, Clinical Research Design & Statistical Analysis Analysis, 2015 - 2017
University of North DakotaResidency, Internal Medicine, 2008 - 2011
University of Aleppo Faculty of MedicineClass of 2005, MD
Certifications & Licensure
MI State Medical License 2017 - 2028
CA State Medical License 2016 - 2026
TX State Medical License 2015 - 2025
ND State Medical License 2008 - 2019
MN State Medical License 2012 - 2018- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow Award Wayne State University - Hematolgoy/Oncology Fellowship, 2020
- FDA-ASCO Hematology-Oncology Fellow Day Workshop Travel Grant American Society of Clinical Oncology (ASCO), 2019
- Awesome Job Award MD Anderson Cancer Center, 2016
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsTargeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy.Husain Yar Khan, Mandana Kamgar, Amro Aboukameel, Sahar Bannoura, Brian Y Chung
Advances in Radiation Oncology. 2022-11-09 - 13 citationsInhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers.Husain Yar Khan, Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md Hafiz Uddin
Cancer Research Communications. 2022-05-01 - 12 citationsSpotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung CancerIbrahim Azar, Samer Alkassis, Jami Fukui, Fares Alsawah, Kalub Fedak
Lung Cancer. 2021-10-07
Other
- Oncology Fellows: Making the Right Decision About Your FutureMohammed Najeeb Al Hallak, OncLive
https://www.onclive.com/view/oncology-fellows-making-the-right-decision-about-your-future
3/11/2020
Professional Memberships
- Member
- American Association for Cancer Research - AACRMember
Other Languages
- Arabic
External Links
- LinkedInhttps://www.linkedin.com/in/mohammed-najeeb-al-hallak-8359088a/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
